Clin2
NCT07506512Likely a fitNot yet recruiting

Time between medicines for early pregnancy loss

Early Pregnancy Loss

Part of Women’s health & pregnancy clinical trials.

This trial compares different waiting times between two medicines used to manage early pregnancy loss. It tests if taking the second medicine right away works as well as waiting 24 hours.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
1,000 people
Ages
Any age
Study type
Interventional

Who can take part

  • You have been diagnosed with a pregnancy that has stopped growing (often called a missed miscarriage).
  • You can give informed consent and are willing to follow the study plan.
  • You have a way to get text messages or emails for follow-up.
  • You can read and understand English.
  • You do not have an incomplete miscarriage or active bleeding.
  • You are not allergic to the study medicines (mifepristone or misoprostol).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06502158Recruiting· Phase 1
Comparing two medications for second-trimester abortion

This trial tests two different medicines (Mifepristone vs Misoprostol) to see which works better for ending a pregnancy in the second trimester (12–16 weeks). It is for people who are pregnant with one baby and have no major health issues that could affect safety.

The Bronx, New York
NCT06733727Not yet recruiting
Comparing two drugs for silent miscarriage management

This trial compares the effectiveness of two medications (letrozole and mifepristone with misoprostol) to help the body pass pregnancy tissue after a silent miscarriage. It may help women who prefer medical treatment over waiting or surgery.

NCT07753655Not yet recruiting
Letrozole before misoprostol for missed abortion

This trial tests whether taking letrozole before misoprostol shortens the time needed to complete a missed abortion, which is when the pregnancy stops developing but the body hasn't expelled the tissue. If effective, it could reduce the waiting time and make the process more efficient.

NCT07526064Not yet recruiting· Phase 1
Oral vs. Vaginal Medicine for Miscarriage Management

This study compares two ways of taking medicine (by mouth or vaginal insertion) to safely manage a miscarriage that was discovered on ultrasound between 8–16 weeks of pregnancy. The goal is to see which method works better and causes fewer side effects.

Islamabad
NCT07767435Not yet recruiting· Phase 1/Phase 2
Comparing two medications for second-trimester abortion

This study compares two medications—letrozole plus misoprostol versus misoprostol alone—to see which is more effective for ending a pregnancy in the second trimester (14–20 weeks) after the fetus has stopped developing. The goal is to find a safer, more comfortable method for women who need this procedure.

NCT05341817Recruiting· Phase 4
Letrozole or mifepristone before medication abortion

This study tests whether taking letrozole or mifepristone before medication helps the medical abortion work better for pregnancies up to 10 weeks. You may be asked to try another method (repeat medicine or a procedure) if the first treatment does not fully work.

Singapore

Hear when a new Early Pregnancy Loss trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.